Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel

Pfizer Inc (PFE.N) is buying Anacor Pharmaceuticals Inc (ANAC.O) in a $5.2 billion deal to add an eczema gel to its portfolio, a month after the U.S. drug major scrapped plans to buy Allergan Plc (AGN.N). Anacor shares rose 54 percent to $98.60 in premarket tr... More »